These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2407810)
21. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1. Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717 [TBL] [Abstract][Full Text] [Related]
22. Randomized trial comparing weekly bolus 5-fluorouracil plus leucovorin versus monthly 5-day 5-fluorouracil plus leucovorin in metastatic colorectal cancer. Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Chen PM Hepatogastroenterology; 2000; 47(36):1599-603. PubMed ID: 11149011 [TBL] [Abstract][Full Text] [Related]
23. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. André T; Bensmaine MA; Louvet C; François E; Lucas V; Desseigne F; Beerblock K; Bouché O; Carola E; Merrouche Y; Morvan F; Dupont-André G; de Gramont A J Clin Oncol; 1999 Nov; 17(11):3560-8. PubMed ID: 10550155 [TBL] [Abstract][Full Text] [Related]
24. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272 [TBL] [Abstract][Full Text] [Related]
25. Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience. Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Yen CC; Fan FS; Hsieh RK Jpn J Clin Oncol; 1998 Jan; 28(1):16-9. PubMed ID: 9491136 [TBL] [Abstract][Full Text] [Related]
26. Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium. Doroshow JH; Leong L; Margolin K; Flanagan B; Goldberg D; Bertrand M; Akman S; Carr B; Odujinrin O; Newman E J Clin Oncol; 1989 Apr; 7(4):439-44. PubMed ID: 2784492 [TBL] [Abstract][Full Text] [Related]
27. [A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer]. Okabo S; Arai T; Maruyama S; Lee M; Murase N; Tsubaki M; Endo M; Wada Y; Shimoju K; Sakurazawa K; Sugihara K; Maruyama M; Yabata E; Kawasaki T; Sasaki T Gan To Kagaku Ryoho; 1997 May; 24(7):849-54. PubMed ID: 9170524 [TBL] [Abstract][Full Text] [Related]
28. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. Budd GT; Fleming TR; Bukowski RM; McCracken JD; Rivkin SE; O'Bryan RM; Balcerzak SP; Macdonald JS J Clin Oncol; 1987 Feb; 5(2):272-7. PubMed ID: 3543246 [TBL] [Abstract][Full Text] [Related]
29. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer. Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799 [TBL] [Abstract][Full Text] [Related]
30. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. Köhne CH; Schöffski P; Wilke H; Käufer C; Andreesen R; Ohl U; Klaasen U; Westerhausen M; Hiddemann W; Schott G; Harstick A; Bade J; Horster A; Schubert U; Hecker H; Dörken B; Schmoll HJ J Clin Oncol; 1998 Feb; 16(2):418-26. PubMed ID: 9469324 [TBL] [Abstract][Full Text] [Related]
31. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer. Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405 [No Abstract] [Full Text] [Related]
32. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma]. Hasegawa S; Akaike M; Yamamoto Y; Shiraishi R; Ozawa Y; Suzuki H; Miyazaki T; Kasahara A; Makino T; Tamura I; Tanabe H; Rino Y Gan To Kagaku Ryoho; 2004 May; 31(5):729-33. PubMed ID: 15170981 [TBL] [Abstract][Full Text] [Related]
33. Continuous 5-fluorouracil infusion and pulse methotrexate/leucovorin for colorectal adenocarcinoma. A report of excessive toxicity. Hansen RM; Quebbeman EJ; Ritch PS; Frick J; Anderson T Am J Clin Oncol; 1987 Jun; 10(3):216-8. PubMed ID: 3496002 [TBL] [Abstract][Full Text] [Related]
34. Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer. Kuo T; Cho CD; Halsey J; Wakelee HA; Advani RH; Ford JM; Fisher GA; Sikic BI J Clin Oncol; 2005 Aug; 23(24):5613-9. PubMed ID: 16110021 [TBL] [Abstract][Full Text] [Related]
35. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D; Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198 [TBL] [Abstract][Full Text] [Related]
36. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study. Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626 [TBL] [Abstract][Full Text] [Related]
37. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer. Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947 [TBL] [Abstract][Full Text] [Related]
38. Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council. Seymour MT; Slevin ML; Kerr DJ; Cunningham D; James RD; Ledermann JA; Perren TJ; McAdam WA; Harper PG; Neoptolemos JP; Nicholson M; Duffy AM; Stephens RJ; Stenning SP; Taylor I J Clin Oncol; 1996 Aug; 14(8):2280-8. PubMed ID: 8708718 [TBL] [Abstract][Full Text] [Related]
39. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study. O'Dwyer PJ; Manola J; Valone FH; Ryan LM; Hines JD; Wadler S; Haller DG; Arbuck SG; Weiner LM; Mayer RJ; Benson AB J Clin Oncol; 2001 May; 19(9):2413-21. PubMed ID: 11331320 [TBL] [Abstract][Full Text] [Related]
40. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Madajewicz S; Petrelli N; Rustum YM; Campbell J; Herrera L; Mittelman A; Perry A; Creaven PJ Cancer Res; 1984 Oct; 44(10):4667-9. PubMed ID: 6331882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]